ABSTRACT OBJECTIVES This study investigated the prevalence of silent myocardial infarction (MI) in patients presenting with first acute myocardial infarction (AMI), and its relation with mortality and major adverse cardiovascular events (MACE) at long-term follow-up.
B
ecause patients after acute myocardial infarction (AMI) are at risk for new events and premature death, secondary prevention is an essential part of patient care. To optimize secondary prevention in these patients, there is a need to identify high-risk subgroups (1, 2) . Previous work has sug- Silent MI constitutes up to 54% of all MIs in the general population and more than 60% in the elderly population older than 60 years, with increasing prevalence in presence of cardiovascular risk factors (3, 5) . Reported prevalence of silent MI ranges from 0.5% to 8.0% in the general population and rises up to 27% in patients with suspected coronary artery disease (CAD) (5) (6) (7) (8) . In these populations the presence of silent MI has been linked to poorer prognosis (3, (7) (8) (9) .
In the setting of AMI only 1 prior study has investigated silent MI. In this study, 7.3% of patients had silent MI detected by Q waves on the ECG, and silent MI was associated with a higher risk of major adverse cardiovascular events (MACE), but not mortality, at short-term follow-up of 90 days (10) .
In addition to the lack of long-term data and current knowledge largely being based on a suboptimal detection method, it is unclear whether silent MI holds prognostic value over important traditional prognos-
ticators (i.e., left ventricular [LV] ejection fraction and
[acute] infarct size). Therefore, the current study assessed, for the first time, the prevalence of silent MI by LGE-CMR in patients presenting with AMI, and its relationship with mortality and MACE after 2 to 12 years follow-up. In addition, the diagnostic accuracy of the ECG for silent MI detection was assessed. Amier et al.
METHODS

In
Prognosis of Silent Myocardial Infarction by CMR CLINICAL OUTCOME. All-cause mortality data were retrieved from the municipal civil registry (Gemeentelijke Basis Administratie) for all patients. MACE was a composite endpoint including all-cause death, reinfarction, coronary artery bypass grafting, and ischemic stroke. In case of multiple MACE endpoints in 1 patient, the date of the first event was used for event-free survival analysis (death > reinfarction > ischemic stroke > coronary artery bypass grafting).
MACE data other than death were retrieved via structured telephone interviews with patients, consisting of the following items: hospitalization for AMI, coronary artery bypass grafting, and/or ischemic stroke; and if yes, the date of hospitalization. The Values are mean AE SD or n (%).
ACE ¼ angiotensin-converting enzyme; AMI ¼ acute myocardial infarction; ARB ¼ angiotensin receptor blocker; CAD ¼ coronary artery disease; LV ¼ left ventricular; MI ¼ myocardial infarction; NA = not applicable; PCI ¼ percutaneous coronary intervention; STEMI ¼ ST-segment elevation myocardial infarction.
Amier et al. were considered statistically significant. patients (8.2%) showed silent MI. Figure 1 shows a Values are n (%).
RESULTS
MACE ¼ major adverse cardiovascular events; other abbreviations as in Table 1 .
Prognosis of Silent Myocardial Infarction by CMR CI ¼ confidence interval; HR ¼ hazard ratio; other abbreviation as in Table 2 .
Amier et al. respectively.
DISCUSSION
The main findings of our study are summarized as follows: 1) previous silent MI was found in 8.2% of patients presenting with first AMI; 2) silent MI by
LGE-CMR was a strong, independent predictor for adverse long-term clinical outcome; and 3) the ECG has limited sensitivity for detection of silent MI and was not associated with long-term clinical outcome in our study cohort. This is the first study in patients with AMI to investigate silent MI using LGE-CMR, and to assess its long-term prognostic implications. LGE-CMR ¼ late gadolinium enhancement cardiac magnetic resonance; other abbreviation as in Table 1 . bypass graft, and ischemic stroke) in patients with and without Q waves by electrocardiogram. Abbreviation as in Figure 1 .
Prognosis of Silent Myocardial Infarction by CMR
Higher risk of mortality and/or MACE after silent MI has consistently been reported in different patient populations with varying follow-up duration (i.e., up to 11 years in the general population [3, 9] , up to 6 years in patients with stable CAD [7, 8] 11.4 in studies using LGE-CMR (7, 8, 12) . In patients with AMI we found HRs of 3.87 and 3.10 for mortality and MACE, respectively, when using LGE-CMR, is not associated with significant atherosclerosis on whole body MR angiography, whereas a history of recognized MI was (13) . Regarding the relation of silent MI with poorer prognosis, silent MIs by
Amier et al. with measuring cardiovascular mortality is that the cause of death is often unclear, in addition to the difficulty of defining cardiovascular mortality, whereas determining all-cause death is objective, reliable, and pragmatic.
The association of silent MI and greater risk of MACE was mainly driven by increased mortality.
Although AMI and ischemic stroke during follow-up were also more frequent in the silent MI group, these differences were not statistically significant and 
CONCLUSIONS
In patients presenting with seemingly first AMI, 8.2%
of patients showed previous silent MI by LGE-CMR.
Moreover, the presence of silent MI was a strong, independent predictor of worse long-term prognosis with a more than 3-fold risk of mortality and MACE.
These results underline the need for clinicians to recognize these patients as a high-risk subgroup.
Future studies are warranted to further investigate pathophysiological mechanisms, preferably using Prognosis of Silent Myocardial Infarction by CMR -2 0 1 8 : ---8
